MoneyWorks4Me

Windlas Biotech informs about grant of stock options

17 Oct 2023 Evaluate
In terms of provisions of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Windlas Biotech has informed that grant of 3,07,750 stock options has been approved by the Nomination and Remuneration Committee of Directors of the Company on 17th October, 2023, and the details are enclosed.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..